Horizon Pharma Raises CEO's Pay 10-Fold to $93.4 Million
Horizon Pharma gave Chief Executive Officer Timothy Walbert a $93.4 million pay package for 2015, a 10-fold increase from the previous year as the company came under scrutiny for its distribution practices.
Walbert received stock options valued at $47.4 million and $43.5 million in restricted shares, according to a preliminary proxy filed Tuesday. The options and about a quarter of the shares will vest over four years, with the remaining stock vesting in 2018 if the firm meets performance targets. His pay package for 2014 was $8.97 million.
Walbert received stock options valued at $47.4 million and $43.5 million in restricted shares, according to a preliminary proxy filed Tuesday. The options and about a quarter of the shares will vest over four years, with the remaining stock vesting in 2018 if the firm meets performance targets. His pay package for 2014 was $8.97 million.